Replies to post #247637 on Biotech Values

[DewDiligence]

LLY/NVO/etc—EMA wants_more_info_on thyroid-cancer risk_of GLP-1 drugs:

https://www.fiercepharma.com/pharma/novo-nordisk-eli-lilly-face-scrutiny-eu-over-glp-1-drugs

The European Medicines Agency has flagged GLP-1 drugs, including Novo Nordisk's Ozempic and Wegovy, and Eli Lilly's Mounjaro, for a potential risk for thyroid cancer. The regulator is asking companies to submit more information by July 26.

Thyroid-cancer risk is a black-box warning in the FDA labels for these drugs.